查詢結果分析
來源資料
相關文獻
- Treatment Results and Prognostic Factors of Esthesioneuroblastoma (ENB)
- 強度調控放射治療技術在嗅神經母細胞瘤之應用
- Long-term Remission of Advanced Esthesioneuroblastoma after Chemoradiotherapy
- Kadish Stage C Olfactory Neuroblastoma Successfully Treated by Chemoradiotherapy: Report of Two Cases
- Postoperative Radiotherapy of Adult Supratentorial High-grade Astrocytoma
- Malignant Primary Extragonadal Germ Cell Tumors of Mediastinum--An Analysis of Clinical and Radiological Features in 15 Cases
- Radiation Therapy in Primary Central Nervous System Lymphoma
- Implications of a Failed Prospective Trial of Adjuvant Therapy after Radical Hysterectomy for Stage Ib-IIa Cervical Carcinoma with Pelvic Node Metastases
- 攝護腺癌之傳統放射線治療--長庚紀念醫院十四年之經驗
- Preoperative Radiotherapy in Patients with Lower Rectal Cancer:Results of Sphincter-Preservation, Treatment Outcome and Morbidities
頁籤選單縮合
題 名 | Treatment Results and Prognostic Factors of Esthesioneuroblastoma (ENB)=嗅神經母細胞瘤治療成果與預後因子 |
---|---|
作 者 | 王友明; 王重榮; 黃英彥; 陳惠君; 孫立民; 方富民; 許軒之; 熊敬業; 黃郁傑; 汪昶佑; | 書刊名 | 放射治療與腫瘤學 |
卷 期 | 12:3 民94.09 |
頁 次 | 頁191-198 |
分類號 | 416.36 |
關鍵詞 | 知覺神經母細胞瘤; 嗅神經母細胞瘤; 放射治療; Esthesioneuroblastoma; Olfactory neuroblastoma; Radiotherapy; |
語 文 | 英文(English) |
中文摘要 | 目的:探討有關於嗅神經母細胞瘤之治療成果與預後因子。 材料與方法:自1989年至2004年共有21位診斷為嗅神經母細胞瘤的病患於本科治療,包括14位男性與7位女性。病患年齡分布自17歲至88歲。我們分析了病患之初期症狀、腫瘤大小、治療方式、與存活時間。10位病患(48%)接受了傳統定位方式的放射治療,11位病患(52%)接受了立體定位順形放射治療。病患之生活活動程度評估依照Karnofsky Performance Scale (KPS)紀錄。腫瘤之分期依據Kadish分期。 結果:在分析的21位病患中2位病患為A期,3位為B期,16位為C期。在35個月的平均追蹤時間後,有4位病患存活,另4位存活但有腫瘤。6位病患發生局病復發,另有5位病患產生遠端轉移。在15位發病初期治有頸部淋巴腫大並沒有接受預防性頸部照射的病患中,3位(20%)發生了頸部復發。整體5年存活率為42%,5年無病存活率為17%。在單變數分析中發現,病患年齡與發病初期之KPS為影響存活率之預後因子。 結論:我們的研究成果與先前文獻中報告過的成果相近。我們發現病患年齡與KPS為影響存活之預後因子。由於頸部復發率在嗅神經母細胞瘤的病患中相對甚高,預防性的頸部照射似乎對病患有幫助。 |
英文摘要 | Purpose: To compare the difference treatment modalities for complications and long-term quality of life (QoL) in patients with stage IB and stage IIA uterine cervical carcinoma. Materials and Methods: Three humdred and thirty-six patients of two institutions were invited to participate in this study. Inclusive patients were follow-up at least 2 years after the completion of the treatment (follow-up periods: 25-218 months) and were between ages 45-74 years. According to the treatment modalities, they were divided into 3 groups: surgery (OP), radiation therapy (RT), and surgery with postoperative radiation therapy (OP+RT). All patients asked to complete the European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ C-30) and complications Questionnaire for the assessment of QoL. Results: Total 8 items of complications were statistically significant, including abdominal pain, diarrhea, constipation, blood stools, dysuria, urine incontinence, edema of lower extremitites and hot flush. Constipation, dysuria, and hot flush were statistically higher in OP group; diarrhea and blood stools were highter in RT group. Significant higher complications treated by OP+RT were: diarrhea, blood stools were higheter in RT group. Significant higher complications treated by OP+RT were: diarrhea, blood stools, urine incontinence and edema of lower extremities. Comparison of EORTC QLQ-C30, the majority of itmes showed little difference among these three treatment modalities, except cognitive functioning and social functioning in functional scales and fatique, nausea/vomiting, poor appetite, constipation and economical difficult in symptoms scales. Conclusion: Our study revealed the different complications in stage IB and Stage IIA uterine cervical cancer patients treated by different modalities, whereas long-term QoL see little difference among these three different modalities. These data were helpful for clinical physician not only for selecting treatment modalities when concerning with QoL changes of the patients, but also for rehabilitation and supportive care of the patients after treatment. |
本系統中英文摘要資訊取自各篇刊載內容。